Catherine Wood's WGS Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 604,561 shares of GeneDx Holdings Corp. (WGS) worth $78.63 M, representing 0.52% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in WGS, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 157,582 shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's GeneDx Holdings (WGS) Holding Value Over Time
Track share changes against reported price movement
Quarterly GeneDx Holdings (WGS) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +157,582 | Add 35.25% | 604,561 | $130.06 |
| Q3 2025 | +446,979 | New Buy | 446,979 | $107.74 |
Catherine Wood's GeneDx Holdings Investment FAQs
Catherine Wood first purchased GeneDx Holdings Corp. (WGS) in Q3 2025, acquiring 446,979 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held GeneDx Holdings Corp. (WGS) for 2 quarters since Q3 2025.
Catherine Wood's largest addition to GeneDx Holdings Corp. (WGS) was in Q3 2025, adding 446,979 shares worth $48.16 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 604,561 shares of GeneDx Holdings Corp. (WGS), valued at approximately $78.63 M.
As of the Q4 2025 filing, GeneDx Holdings Corp. (WGS) represents approximately 0.52% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in GeneDx Holdings Corp. (WGS) was 604,561 shares, as reported at the end of Q4 2025.